Alena Skrahina - Concepedia

Author

Alena Skrahina

Republican Scientific and Practical Centre of Pulmonology and Tuberculosis ORCID

Also Known As

A Skrahina, A. M. Skrahina, A. Skrahina, A.M. Skrahina, Alena M. Skrahina, Alena Skrahina, Justin Denholm, Skrahina A, Skrahina, A.

159

Publications

8.1K

Citations

H-Index

Concepts

All Affiliations

Republican Scientific and Practical Centre of Pulmonology and Tuberculosis Karolinska Institutet University Medical Center Groningen University of Groningen World Health Organization

About

Alena Skrahina is an author at Republican Scientific and Practical Centre of Pulmonology and Tuberculosis specializing in tuberculosis, medicine, and drug resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	17	1.6K
2	Health Sciences	6	6	969
3	Public Health	5	5	262
4	Epidemiology	3	3	225
5	Global Health	1	1	11

Alena Skrahina

Publications

5.5K

Citations

H-Index

Page 1

	Year	Citations
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study Susan E. Dorman, Samuel G. Schumacher, David Alland, The Lancet Infectious Diseases	2017	666
The New Xpert MTB/RIF Ultra: Improving Detection of <i>Mycobacterium tuberculosis</i> and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing Soumitesh Chakravorty, Ann Marie Simmons, Mazhgan Rowneki, mBio	2017	632
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study Keertan Dheda, Martin Enwerem, Rodolfo Romero Leyet, European Respiratory Journal Pulmonary TuberculosisHealth SciencesBedaquiline-containing RegimensMulticentre StudyPharmacology	2017	294
Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance Abigail L. Manson, Keira A. Cohen, Thomas Abeel, Nature Genetics Medical MicrobiologyPulmonary TuberculosisAntimicrobial Resistance GeneHealth SciencesGenomic Analysis	2017	287
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis Paolo Miotto, Claudio U. Köser, Philip W. Fowler, The Lancet Microbe	2022	282
A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis Giovanni Battista Migliori, B Eker, Malcolm Richardson, European Respiratory Journal Drug SafetyMultidrug-resistant TuberculosisMdr/xdr-tb TreatmentPulmonary TuberculosisHealth Sciences	2009	187
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report Edvardas Danila, Andrei Maryandyshev, Margareth Pretti Dalcolmo, European Respiratory Journal	2019	168
Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project Matteo Zignol, Anna Dean, Natavan Alikhanova, The Lancet Infectious Diseases	2016	164
Population structure, biogeography and transmissibility of Mycobacterium tuberculosis Luca Freschi, Roger Vargas, Ashaque Husain, Nature Communications	2021	162
Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors Alena Skrahina, Henadz Hurevich, Aksana Zalutskaya, Bulletin of the World Health Organization	2012	161

Page 1